Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Edouard L, Fu"'
Autor:
Sebastian Hödlmoser, Juan Jesus Carrero, Amelie Kurnikowski, Edouard L. Fu, Oskar Swartling, Wolfgang C. Winkelmayer, Eva S. Schernhammer, Manfred Hecking
Publikováno v:
Kidney International Reports, Vol 7, Iss 3, Pp 444-454 (2022)
Introduction: Women are more likely to have chronic kidney disease (CKD), compared with men, yet they are less likely to receive dialysis. Whether this sex disparity, which has predominantly been observed in nephrology-referred or CKD-specific cohort
Externí odkaz:
https://doaj.org/article/11b4767431dd4eee82550b9803a5f4bd
Autor:
Jaimie L. H. Zhang, Natasha M. Appelman-Dijkstra, Edouard L. Fu, Joris I. Rotmans, Abbey Schepers
Publikováno v:
BMC Nephrology, Vol 22, Iss 1, Pp 1-9 (2021)
Abstract Background Renal hyperparathyroidism is a disease entity that is complex and poorly understood. Although there are guidelines regarding how to manage this patient group, evidence is scarce. Therefore, this survey-based study aims to map the
Externí odkaz:
https://doaj.org/article/667927d90d1543c5b459bcb2fa668fd5
Autor:
Patrick Bidulka, Edouard L. Fu, Clémence Leyrat, Fotini Kalogirou, Katherine S. L. McAllister, Edward J. Kingdon, Kathryn E. Mansfield, Masao Iwagami, Liam Smeeth, Catherine M. Clase, Krishnan Bhaskaran, Merel van Diepen, Juan-Jesus Carrero, Dorothea Nitsch, Laurie A. Tomlinson
Publikováno v:
BMC Medicine, Vol 18, Iss 1, Pp 1-11 (2020)
Abstract Background The safety of restarting angiotensin-converting enzyme inhibitors (ACEI) or angiotensin II receptor blockers (ARB) after acute kidney injury (AKI) is unclear. There is concern that previous users do not restart ACEI/ARB despite on
Externí odkaz:
https://doaj.org/article/0fe9886e50034fe48ce305184b3d26d7
Autor:
Gurbey Ocak, Meriem Khairoun, Othman Khairoun, Willem Jan W Bos, Edouard L Fu, Maarten J Cramer, Jan Westerink, Marianne C Verhaar, Frank L Visseren, UCC-SMART study group
Publikováno v:
PLoS ONE, Vol 17, Iss 4, p e0266046 (2022)
BackgroundChronic kidney disease (CKD) and atrial fibrillation (AF) are both risk factors for bleeding, stroke and mortality. The aim of our study was to investigate the interaction between CKD and atrial fibrillation and outcomes.MethodsWe included
Externí odkaz:
https://doaj.org/article/e06e042be60940019ae36c3cdf2fbf6d
Publikováno v:
Clinical Journal of the American Society of Nephrology. 18:592-601
Autor:
Juan Jesus Carrero, Edouard L. Fu, Søren V. Vestergaard, Simon Kok Jensen, Alessandro Gasparini, Viyaasan Mahalingasivam, Samira Bell, Henrik Birn, Uffe Heide-Jørgensen, Catherine M. Clase, Faye Cleary, Josef Coresh, Friedo W. Dekker, Ron T. Gansevoort, Brenda R. Hemmelgarn, Kitty J. Jager, Tazeen H. Jafar, Csaba P. Kovesdy, Manish M. Sood, Bénédicte Stengel, Christian F. Christiansen, Masao Iwagami, Dorothea Nitsch
Publikováno v:
Carrero, J J, Fu, E L, Vestergaard, S V, Jensen, S K, Gasparini, A, Mahalingasivam, V, Bell, S, Birn, H, Heide-Jørgensen, U, Clase, C M, Cleary, F, Coresh, J, Dekker, F W, Gansevoort, R T, Hemmelgarn, B R, Jager, K J, Jafar, T H, Kovesdy, C P, Sood, M M, Stengel, B, Christiansen, C F, Iwagami, M & Nitsch, D 2023, ' Defining measures of kidney function in observational studies using routine health care data : methodological and reporting considerations ', Kidney International, vol. 103, no. 1, pp. 53-69 . https://doi.org/10.1016/j.kint.2022.09.020
The availability of electronic health records and access to a large number of routine measurements of serum creatinine and urinary albumin enhance the possibilities for epidemiologic research in kidney disease. However, the frequency of health care u
Publikováno v:
Kidney International. 103:30-33
The novel nonsteroidal mineralocorticoid receptor antagonist finerenone has been shown to reduce the risk of kidney and cardiovascular outcomes in patients with type 2 diabetes and chronic kidney disease. In this issue of Kidney International, Bakris
Autor:
Jim, Alkas, Alessandro, Bosi, Arvid, Sjölander, Peter, Barany, Carl-Gustaf, Elinder, Edouard L, Fu, Juan Jesus, Carrero
Publikováno v:
Journal of Nephrology. 36:705-711
Introduction Little is known about the comparative effects of sodium glucose cotransporter-2 inhibitors (SGLT2i), glucagon-like peptide-1 receptor agonists (GLP1-RA), or dipeptidyl peptidase-4 inhibitors (DPP-4i) on the risk of acute kidney injury (A
Autor:
Oskar Swartling, Yuanhang Yang, Catherine M. Clase, Edouard L. Fu, Manfred Hecking, Sebastian Hödlmoser, Ylva Trolle-Lagerros, Marie Evans, Juan J. Carrero
Publikováno v:
Journal of the American Society of Nephrology. 33:1903-1914
Reported sex differences in the etiology, population prevalence, progression rates, and health outcomes of people with CKD may be explained by differences in health care.We evaluated sex as the variable of interest in a health care-based study of adu
Autor:
Edouard L. Fu
Publikováno v:
Journal of the American Society of Nephrology.